Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
InFinT Acquisition | IFIN | Jul 26, 2024 | 11.70 | +0.09 |
InflaRx N.V | IFRX | Jul 26, 2024 | 1.53 | 0.00 |
Inflection Point Acquisition II | IPXX | Jul 26, 2024 | 10.66 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | Jul 26, 2024 | 10.66 | +0.19 |
Infobird | IFBD | Jul 26, 2024 | 2.56 | -2.29 |
Informatica | INFA | Jul 26, 2024 | 24.27 | +1.17 |
Information Services Group | III | Jul 26, 2024 | 3.52 | -0.85 |
Information Technology ETF Vanguard | VGT | Jul 26, 2024 | 561.56 | +1.18 |
Infosys ADR | INFY | Jul 26, 2024 | 22.79 | +3.54 |
InfuSystems | INFU | Jul 26, 2024 | 6.90 | 0.00 |
ING Group ADR | ING | Jul 26, 2024 | 18.57 | +1.20 |
Ingersoll Rand | IR | Jul 26, 2024 | 98.70 | +1.82 |
Ingevity | NGVT | Jul 26, 2024 | 46.20 | +0.79 |
Ingles Markets A | IMKTA | Jul 26, 2024 | 79.73 | +0.96 |
Ingredion | INGR | Jul 26, 2024 | 121.21 | +1.24 |
Inhibikase Therapeutics | IKT | Jul 26, 2024 | 1.60 | -0.31 |
Inhibrx Biosciences | INBX | Jul 26, 2024 | 13.73 | +2.23 |
InMed | INM | Jul 26, 2024 | 0.29 | +2.67 |
InMode | INMD | Jul 26, 2024 | 17.89 | +1.65 |
INmune Bio | INMB | Jul 26, 2024 | 8.58 | +1.30 |
Innate Pharma ADR | IPHA | Jul 26, 2024 | 2.13 | +1.91 |
Inno Holdings | INHD | Jul 26, 2024 | 0.72 | -3.85 |
Innodata | INOD | Jul 26, 2024 | 19.76 | +14.09 |
Innospec | IOSP | Jul 26, 2024 | 130.22 | +1.66 |
InnovAge | INNV | Jul 26, 2024 | 6.35 | +3.25 |
Innovate | VATE | Jul 26, 2024 | 0.65 | +1.88 |
Innovative Eyewear | LUCY | Jul 26, 2024 | 5.24 | +0.58 |
Innovative Industrial Properties | IIPR | Jul 26, 2024 | 122.93 | +1.81 |
Innovative Industrial Properties A Pref | IIPR-A | Jul 26, 2024 | 27.90 | -0.53 |
Innovative Solutions and Support | ISSC | Jul 26, 2024 | 6.27 | +7.18 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.